Pancreatic Cancer Research

ResearcherChristian-Albrechts-Universität zu KielNo recent work listed

Angela Zaccagnino

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-1739-3017; OpenAlex author ID A5035573865. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. The A818-6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer. First author DOI 10.1186/s12885-020-06773-w↗
  2. Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.11299↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna Trauzold · 2 shared papers, 2017–2020 · strength 0.18
  2. Holger Kalthoff · 2 shared papers, 2017–2020 · strength 0.18
  3. Albrecht Schwab · 1 shared paper, 2020 · strength 0.12
  4. Doaa Tawfik · 1 shared paper, 2020 · strength 0.12
  5. Karen Legler · 1 shared paper, 2017 · strength 0.06
  6. Roberta Peruzzo · 1 shared paper, 2017 · strength 0.06
  7. Luigi Leanza · 1 shared paper, 2017 · strength 0.06
  8. Lucia Biasutto · 1 shared paper, 2017 · strength 0.06
  9. Ildikò Szabó · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.